Azisan Plus 40/12.5 Tablet

About Azisan Plus 40/12.5 Tablet

Azisan Plus 40/12.5 is a tablet combining azilsartan medoxomil and chlorthalidone. Azilsartan relaxes blood vessels, while chlorthalidone helps the kidneys remove extra salt and water, working together to lower blood pressure.

What is Azisan Plus 40/12.5 Tablet?

Azisan Plus 40/12.5 is a prescription tablet made by Renata PLC. It contains two blood pressure medicines: azilsartan medoxomil, which blocks a hormone that narrows blood vessels, and chlorthalidone, a diuretic that helps the body pass extra salt and water. Together they lower blood pressure when one medicine alone is not enough. It is used for hypertension and may reduce the risk of serious heart problems like strokes and heart attacks. The doctor decides the dose and course. Store it in a cool, dry place away from light and children.

Uses of Azisan Plus 40/12.5

Azisan Plus 40/12.5 is used to treat high blood pressure (hypertension). It is for people whose blood pressure is not controlled with a single blood pressure medicine, or who are likely to need more than one medicine. Lowering blood pressure helps reduce the risk of fatal and nonfatal cardiovascular events, mainly strokes and heart attacks. Only a doctor can decide if this medicine is right for you.

How to use Azisan Plus 40/12.5

Take Azisan Plus 40/12.5 exactly as your doctor tells you. The doctor decides the dose and how long you take it. Swallow the tablet with water. You can take it with or without food, but follow your doctor's advice. Do not stop taking it without talking to your doctor, even if you feel well. If you miss a dose, ask your doctor or pharmacist what to do. Keep the tablet in a cool, dry place away from light and children.

Side effects of Azisan Plus 40/12.5

Like all medicines, Azisan Plus 40/12.5 can cause side effects. The known potential side effects include low blood pressure when you stand up (especially if you are low on salt or water), kidney problems, low potassium levels, and high uric acid levels. It can also harm an unborn baby. If you notice any unusual symptoms, tell your doctor right away. Your doctor may check your kidney function and mineral levels during treatment.

Safety and precautions

Do not take Azisan Plus 40/12.5 if you have anuria (the kidneys do not make urine). Before starting, tell your doctor if you have kidney problems, kidney artery narrowing, low salt or water in your body, heart rhythm problems, liver problems, or low potassium or magnesium. It is pregnancy category D and can harm the fetus, especially in the second and third trimesters. Do not use it during pregnancy. Ask your doctor before use if you are breastfeeding. Your doctor may adjust or stop other medicines. Always ask your doctor or pharmacist if you have questions.

Frequently asked questions

Who should avoid Azisan Plus 40/12.5 or ask the doctor first?

Do not take it if you have anuria. Ask your doctor first if you have kidney problems, kidney artery narrowing, low salt or water levels, heart rhythm problems, liver problems, or low potassium or magnesium. Also tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.

What is Azisan Plus 40/12.5 used for and what kind of medicine is it?

It is used to treat high blood pressure (hypertension). It is a combination of two medicines: azilsartan medoxomil, an angiotensin II receptor blocker (ARB), and chlorthalidone, a diuretic. It is for people whose blood pressure is not controlled with one medicine or who likely need multiple medicines.

What does the generic name Azilsartan Medoxomil + Chlorthalidone mean?

Azilsartan medoxomil is an ARB that works by relaxing blood vessels and helping the body excrete sodium and water. Chlorthalidone is a diuretic that helps the kidneys flush out excess water and salt. Together they lower blood pressure.

What should I know about storing Azisan Plus 40/12.5?

Store the tablets in a cool, dry place away from light and out of reach of children. Do not use after the expiry date. Ask your pharmacist if you are unsure how to dispose of unused tablets.

Indications

For the treatment of hypertension, to lower blood pressure:
  • In patients not adequately controlled with ARB monotherapy
  • As initial therapy in patients likely to need multiple drugs to help
To achieve blood pressure goals and to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

Pharmacology

Azilsartan medoxomil is an angiotensin II receptor blocker (ARB). Azilsartan helps blood vessels to dilate. It also helps to excrete of Sodium and water from body. This combination also contains a diuretic. Chlorthalidone works in the kidneys to flush excess water and salt (sodium) from the body. Together, these 2 medicines work to help lower blood pressure in people who need more than 1 medicine to treat their high blood pressure (hypertension).

Dosage & Administration

The recommended starting dose is 40/12.5 mg taken orally once daily. Most of the antihypertensive effect is apparent within 1 to 2 weeks. This combination may be used to provide additional blood pressure lowering for patients not adequately controlled on ARB or diuretic monotherapy treatment. Patients not controlled with azilsartan medoxomil 80 mg may have an additional systolic/diastolic clinic blood pressure reduction of 13/6 mm Hg when switched to this combination 40/12.5 mg.

This combination may be used as initial therapy if a patient is likely to need multiple drugs to achieve blood pressure goals. Patients titrated to the individual components (azilsartan medoxomil and chlorthalidone) may instead receive the corresponding dose of This combination.

Interaction

Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity. NSAIDs increase risk of renal dysfunction and interfere with antihypertensive effect

Contraindications

This is contraindicated in patients with anuria.

Side Effects

The following potential adverse reactions are-
  • Fetal toxicity
  • Hypotension in Volume- or Salt-Depleted Patients
  • Impaired Renal Function
  • Hypokalemia Hyperuricemia

Pregnancy & Lactation

Pregnancy Category D. Use of drugs that affect the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.

Precautions & Warnings

  • In patients with an activated renin-angiotensin-aldosterone system (RAAS), such as volume- and/or salt-depleted patients, this combination can cause excessive hypotension. Correct volume or salt depletion prior to administration of azilsartan and chlorthalidone.
  • In patients with renal artery stenosis, This combination may cause renal failure.
  • Monitor renal function in patients with renal impairment. Consider discontinuing this combination with progressive renal impairment.
  • Heart rhythm problems (e.g., bradycardia, QT prolongation, ventricular tachycardia), liver problems, certain uncorrected mineral imbalances (low potassium/magnesium levels), severe kidney problems.

Storage Conditions

Store in a cool & dry place, away from light and children.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.